The gut microbiome influences the bioavailability of olanzapine in rats.

dc.contributor.authorCussotto, Sofia
dc.contributor.authorWalsh, Jacinta
dc.contributor.authorGolubeva, Anna V.
dc.contributor.authorZhdanov, Alexander V.
dc.contributor.authorStrain, Conall R.
dc.contributor.authorFouhy, Fiona
dc.contributor.authorStanton, Catherine
dc.contributor.authorDinan, Timothy G.
dc.contributor.authorHyland, Niall P.
dc.contributor.authorClarke, Gerard
dc.contributor.authorCryan, John F.
dc.contributor.authorGriffin, Brendan T.
dc.contributor.funderYakult Bio-Science Foundationen
dc.date.accessioned2021-10-06T11:49:04Z
dc.date.available2021-10-06T11:49:04Z
dc.date.issued2021-04-02
dc.date.updated2021-10-06T11:20:25Z
dc.description.abstractBackground: The role of the gut microbiome in the biotransformation of drugs has recently come under scrutiny. It remains unclear whether the gut microbiome directly influences the extent of drug absorbed after oral administration and thus potentially alters clinical pharmacokinetics. Methods: In this study, we evaluated whether changes in the gut microbiota of male Sprague Dawley rats, as a result of either antibiotic or probiotic administration, influenced the oral bioavailability of two commonly prescribed antipsychotics, olanzapine and risperidone. Findings: The bioavailability of olanzapine, was significantly increased (1.8-fold) in rats that had undergone antibiotic-induced depletion of gut microbiota, whereas the bioavailability of risperidone was unchanged. There was no direct effect of microbiota depletion on the expression of major CYP450 enzymes involved in the metabolism of either drug. However, the expression of UGT1A3 in the duodenum was significantly downregulated. The reduction in faecal enzymatic activity, observed during and after antibiotic administration, did not alter the ex vivo metabolism of olanzapine or risperidone. The relative abundance of Alistipes significantly correlated with the AUC of olanzapine but not risperidone. Interpretation: Alistipes may play a role in the observed alterations in olanzapine pharmacokinetics. The gut microbiome might be an important variable determining the systemic bioavailability of orally administered olanzapine. Additional research exploring the potential implication of the gut microbiota on the clinical pharmacokinetics of olanzapine in humans is warranted.en
dc.description.sponsorshipNature Research-Yakult (The Global Grants for Gut Health; Ref No. 626891).en
dc.description.statusPeer revieweden
dc.description.versionPublished Versionen
dc.format.mimetypeapplication/pdfen
dc.identifier.articleid103307en
dc.identifier.citationCussotto, S., Walsh, J., Golubeva, A. V., Zhdanov, A. V., Strain, C. R., Fouhy, F., Stanton, C., Dinan, T. G., Hyland, N. P., Clarke, G., Cryan, J. F. and Griffin, B. T. (2021) 'The gut microbiome influences the bioavailability of olanzapine in rats', EBioMedicine, 66, 103307 (14 pp). doi: 10.1016/j.ebiom.2021.103307en
dc.identifier.doi10.1016/j.ebiom.2021.103307en
dc.identifier.endpage14en
dc.identifier.issn2352-3964
dc.identifier.journaltitleEbiomedicineen
dc.identifier.startpage1en
dc.identifier.urihttps://hdl.handle.net/10468/12057
dc.identifier.volume66en
dc.language.isoenen
dc.publisherElsevieren
dc.relation.projectinfo:eu-repo/grantAgreement/SFI/SFI Research Centres/12/RC/2273/IE/Alimentary Pharmabiotic Centre (APC) - Interfacing Food & Medicine/en
dc.relation.urihttps://www.sciencedirect.com/science/article/pii/S2352396421001006
dc.rights© 2021 The Author(s). Published by Elsevier B.V. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/)en
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/en
dc.subjectAntipsychoticen
dc.subjectMicrobiomeen
dc.subjectPharmacokineticsen
dc.subjectDiversityen
dc.subjectBioavailabilityen
dc.subjectCYPen
dc.titleThe gut microbiome influences the bioavailability of olanzapine in rats.en
dc.typeArticle (peer-reviewed)en
Files
Original bundle
Now showing 1 - 4 of 4
Loading...
Thumbnail Image
Name:
1-s2.0-S2352396421001006-main.pdf
Size:
3.62 MB
Format:
Adobe Portable Document Format
Description:
Published version
Loading...
Thumbnail Image
Name:
1-s2.0-S2352396421001006-mmc1.pdf
Size:
169.09 KB
Format:
Adobe Portable Document Format
Description:
Supplementary material 1
Loading...
Thumbnail Image
Name:
1-s2.0-S2352396421001006-mmc2.pdf
Size:
700.81 KB
Format:
Adobe Portable Document Format
Description:
Supplementary material 2
Loading...
Thumbnail Image
Name:
1-s2.0-S2352396421001006-mmc3.pdf
Size:
2.65 MB
Format:
Adobe Portable Document Format
Description:
Supplementary material 3
License bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
2.71 KB
Format:
Item-specific license agreed upon to submission
Description: